{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:20:07Z","timestamp":1774542007977,"version":"3.50.1"},"reference-count":51,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2005,8,22]],"date-time":"2005-08-22T00:00:00Z","timestamp":1124668800000},"content-version":"vor","delay-in-days":1178,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Cancer Research"],"published-print":{"date-parts":[[2002,6]]},"abstract":"<jats:p>B\u2010Cell chronic lymphocytic leukemia (B\u2010CLL)\/small lymphocytic lymphoma (SLL) consists of heterogeneous diseases that are distinguished by morphological, immunophenotypic and molecular features. <jats:italic>MUM1<\/jats:italic> (multiple myeloma oncogene 1) is a protooncogene that is deregulated as a result of (6;14)(p25;q32) chromosomal translocation in multiple myeloma, and is also expressed in a variety of malignant lymphoma entities. We examined the expression of MUM1 in B\u2010CLL\/SLL, and found that 2 of 4 B\u2010CLL\u2010derived cell lines and 14 of 29 patients' specimens expressed MUM1 by immunohistochemical analysis. MUM1 expression was not associated with CD38 expression, somatic hypermutation of immunoglobulin heavy chain gene variable region (IgV<jats:sub>H<\/jats:sub>), or any other clinical characteristics of the patients. Interestingly, the patients who were positive for MUM1 showed shorter overall survival tunes than those who were negative for MUM1 (50% survival: 22 months vs. 82 months) (P=0.0008, log\u2010rank test). Multivariate analysis by Cox's proportional\u2010hazards regression model showed that MUM1 expression and unmutated IgV<jats:sub>H<\/jats:sub> status were independent unfavorable prognostic factors in patients with B\u2010CLL\/SLL. These findings suggest that MUM1 expression is a useful prognostic factor in B\u2010CLL\/SLL. The biological role and mechanism of action of MUM1 in B\u2010CLL\/SLL need to be clarified for the development of therapies for patients with the poor prognostic subtype.<\/jats:p>","DOI":"10.1111\/j.1349-7006.2002.tb01307.x","type":"journal-article","created":{"date-parts":[[2005,8,22]],"date-time":"2005-08-22T10:42:25Z","timestamp":1124707345000},"page":"685-694","source":"Crossref","is-referenced-by-count":27,"title":["MUM1\/IRF4 Expression Is an Unfavorable Prognostic Factor in B\u2010Cell Chronic Lymphocytic Leukemia (CLL)\/Small Lymphocytic Lymphoma (SLL)"],"prefix":"10.1111","volume":"93","author":[{"given":"Masato","family":"Ito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoko","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritsuro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Seto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuzo","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,8,22]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","DOI":"10.1201\/9781420002287","volume-title":"Chronic Lymphoid Leukemias","author":"Cheson B. D.","year":"2001"},{"key":"e_1_2_1_3_2","first-page":"1308","volume-title":"Hematology: Basic Principles and Practice","author":"Rai K.","year":"1995"},{"key":"e_1_2_1_4_2","first-page":"3","article-title":"Immunologic studies of chronic lymphocytic leukemia and non\u2010Hodgkin's lymphoma in Nagasaki district","volume":"9","author":"Kamihira S.","year":"1979","journal-title":"Jpn. J. Clin. Oncol."},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199409114147"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.2.307.307"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-200001000-00004"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V46.2.219.219"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V genemutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle R. N.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.6.1848"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.1.181"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1182\/blood.V95.7.2455","article-title":"Immunoglobulin V genes and CD38 expression in CLL [letter]","volume":"95","author":"Hamblin T. J.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012283432602"},{"key":"e_1_2_1_15_2","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1182\/blood.V89.11.4153","article-title":"Differential rates of somatic hypermutation in V(H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities","volume":"89","author":"Oscier D. G.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1097-226"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401563"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.16.4.1283"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/18.4.977"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.12.1837"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.10.6104"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401696"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.6.2084"},{"key":"e_1_2_1_24_2","first-page":"633","article-title":"Quantification of multiple myeloma oncogene 1\/interferon\u2010regulatory factor 4 gene expression in malignant B\u2010cell proliferations and normal leukocytes","volume":"21","author":"Yamada M.","year":"2001","journal-title":"Anticancer Res."},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880373"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/35000501"},{"key":"e_1_2_1_27_2","first-page":"127","volume-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Muller\u2010Hermelink H. K.","year":"2001"},{"key":"e_1_2_1_28_2","first-page":"130","article-title":"Establishment of a human B\u2010CLL xenograft model: utility as a preclinical therapeutic model","volume":"10","author":"Mohammad R. M.","year":"1996","journal-title":"Leukemia"},{"key":"e_1_2_1_29_2","first-page":"476","article-title":"Epstein\u2010Barr virus (EBV) can immortalize B\u2010CLL cells activated by cytokines","volume":"8","author":"Wendel\u2010Hansen V.","year":"1994","journal-title":"Leukemia"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(93)90154-D"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(98)00154-4"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2001.tb01142.x"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-97187-7"},{"key":"e_1_2_1_34_2","first-page":"1401","article-title":"Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation","volume":"7","author":"Seto M.","year":"1992","journal-title":"Oncogene"},{"key":"e_1_2_1_35_2","first-page":"1398","article-title":"Burkitt's lymphomas express VH genes with a moderate number of antigen\u2010selected somatic mutations","volume":"147","author":"Tamaru J.","year":"1995","journal-title":"Am. J. Pathol."},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01697401"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.4723278.x"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.6.1580.bloodjournal8561580"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.9.3148.3148"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.11.4342.411k39_4342_4349"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711540305"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.01898.x"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb08169.x"},{"key":"e_1_2_1_44_2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/blood.V82.2.571.571","article-title":"Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype, and morphology","volume":"82","author":"Que T. H.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.1994.tb02926.x"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1993.tb03338.x"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.21.19.6369-6386.2001"},{"key":"e_1_2_1_48_2","first-page":"4918","article-title":"Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia","volume":"58","author":"Bechter O. E.","year":"1998","journal-title":"Cancer Res."},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1078>3.0.CO;2-C"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(00)00536-1"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5299.540"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V71.4.1157.1157"}],"container-title":["Japanese Journal of Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2002.tb01307.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2002.tb01307.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T22:12:08Z","timestamp":1700259128000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2002.tb01307.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["10.1111\/j.1349-7006.2002.tb01307.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2002.tb01307.x","archive":["Portico"],"relation":{},"ISSN":["0910-5050"],"issn-type":[{"value":"0910-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2002,6]]}}}